Chicago Partners Investment Group’s Alpha Tau Medical Warrant DRTSW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-73,824
Closed -$76K 1618
2026
Q1
$76K Sell
73,824
-112,000
-60% -$108K ﹤0.01% 1408
2025
Q4
$172K Sell
185,824
-30,000
-14% -$10.1K ﹤0.01% 1244
2025
Q3
$82.2K Hold
215,824
﹤0.01% 1193
2025
Q2
$49.6K Hold
215,824
﹤0.01% 1079
2025
Q1
$39.9K Hold
215,824
﹤0.01% 918
2024
Q4
$45.3K Hold
215,824
﹤0.01% 840
2024
Q3
$35.1K Hold
215,824
﹤0.01% 791
2024
Q2
$36.7K Buy
215,824
+10,000
+5% +$2.37K ﹤0.01% 739
2024
Q1
$43.2K Hold
205,824
﹤0.01% 726
2023
Q4
$60.6K Buy
205,824
+2,500
+1% +$605 ﹤0.01% 684
2023
Q3
$52.9K Hold
203,324
﹤0.01% 641
2023
Q2
$62.4K Hold
203,324
﹤0.01% 668
2023
Q1
$52.5K Hold
203,324
﹤0.01% 648
2022
Q4
$85.4K Buy
203,324
+16,404
+9% +$5.02K 0.01% 622
2022
Q3
$58K Buy
186,920
+56,020
+43% +$33.1K ﹤0.01% 576
2022
Q2
$82K Hold
130,900
0.01% 576
2022
Q1
$55K Buy
+130,900
New +$71.4K ﹤0.01% 550

Other funds holding DRTSW

Chicago Partners Investment Group's DRTSW Position: Q2 2026 in Review

Chicago Partners Investment Group sold out of Alpha Tau Medical Warrant (DRTSW) in Q2 2026, closing a stake of 73,824 shares — an estimated $76K sold.

Chicago Partners Investment Group first reported a position in DRTSW in Q1 2022 and held it in 17 quarters. The position peaked at $172K in Q4 2025. 21 funds tracked by Wall St. Rank hold DRTSW as of Q2 2026.

  • Chicago Partners Investment Group reported no remaining Alpha Tau Medical Warrant position as of Q2 2026 after selling out during the quarter.
  • Chicago Partners Investment Group sold 73,824 Alpha Tau Medical Warrant shares in Q2 2026, an estimated $76K.
  • Chicago Partners Investment Group first reported a position in Alpha Tau Medical Warrant in Q1 2022 and held it in 17 quarters.
  • Chicago Partners Investment Group's Alpha Tau Medical Warrant position peaked at $172K in Q4 2025.
  • 21 funds tracked by Wall St. Rank held Alpha Tau Medical Warrant as of Q2 2026.

Based on Chicago Partners Investment Group's 13F filing for Q2 2026, filed 30 Jul 2026.